title: Toward interchangeable biologics.
abstract: A biosimilar is designed to match the reference product--to be as close to the reference as the reference is to itself considering batch-to-batch variability and manufacturing changes over its lifetime. Interchangeability will require additional data, however, the interchangeable biologic itself will be the same as that approved for biosimilarity.
authors: Department of Biopharmaceutical & Oncology Injectables Development, Sandoz International GmbH, Holzkirchen, Germany.
authors: M
authors: M
authors: McCamish
authors: J
authors: J
authors: Pakulski
authors: C
authors: C
authors: Sattler
authors: G
authors: G
authors: Woollett
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000592:standards*; D017277:Drug Approval; D055808:Drug Discovery / Q000592:standards*; D006801:Humans
chemical_list: D059451:Biosimilar Pharmaceuticals